UPDATED Apr 15, 2024
Annually loss-making mid-caps and large-caps with sound financial health.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MLTX | US$43.64 | -5.7% | 105.8% | US$2.8b | US$73.38 | PB5.5x | E3.0% | n/a | Pharmaceuticals & Biotech | ||
LCID | US$2.43 | -8.0% | -69.4% | US$5.7b | US$3.30 | PS9.4x | E28.6% | n/a | Automobiles | ||
ARWR | US$24.01 | -6.6% | -23.4% | US$3.1b | US$55.15 | PS16.4x | E21.8% | n/a | Pharmaceuticals & Biotech | ||
VERA | US$46.53 | 20.5% | 629.3% | US$2.6b | US$50.11 | PB24.9x | E26.5% | n/a | Pharmaceuticals & Biotech | ||
CERE | US$41.70 | -1.2% | 61.6% | US$7.6b | US$44.78 | PB11.2x | E12.5% | n/a | Pharmaceuticals & Biotech | ||
S | US$20.67 | -9.8% | 17.0% | US$6.7b | US$29.71 | PS10.3x | E39.7% | n/a | Software | ||
DCT | US$18.99 | 0% | -0.3% | US$2.6b | n/a | PS8.4x | E45.0% | n/a | Software | ||
SAIL | US$65.24 | 1.5% | 49.7% | US$6.2b | US$65.86 | PS12.5x | E11.3% | n/a | Software | ||
ARVN | US$34.72 | -7.8% | 23.3% | US$2.5b | US$70.83 | PS30.1x | E27.1% | n/a | Pharmaceuticals & Biotech | ||
PRCT | US$50.60 | 2.4% | 36.9% | US$2.6b | US$56.67 | PS18.9x | E37.0% | n/a | Healthcare | ||
QS | US$5.41 | -11.9% | -32.4% | US$2.9b | US$7.02 | PB2x | E-3.3% | n/a | Automobiles | ||
MNDT | US$22.98 | 0.5% | 24.8% | US$5.4b | US$20.80 | PS10.3x | E27.1% | n/a | Software | ||
DICE | US$47.55 | 0.2% | 131.2% | US$2.3b | US$48.00 | PB4.4x | E-22.3% | n/a | Pharmaceuticals & Biotech | ||
NXT | AU$15.41 | -8.2% | 27.6% | AU$8.2b | AU$18.24 | PS18.7x | E10.4% | n/a | Software | ||
SG | US$21.08 | -16.1% | 164.8% | US$2.6b | US$21.29 | PS4.1x | E22.9% | n/a | Consumer Services | ||
PLAN | US$63.73 | 0.6% | 16.3% | US$9.6b | US$64.21 | PS15.2x | E4.3% | n/a | Software | ||
VKTX | US$66.95 | -11.8% | 241.1% | US$7.6b | US$108.44 | PB21.2x | E1.8% | n/a | Pharmaceuticals & Biotech | ||
DYN | US$25.44 | -5.4% | 166.7% | US$2.2b | US$37.56 | PB24x | E20.1% | n/a | Pharmaceuticals & Biotech | ||
TXG | US$32.86 | -10.0% | -38.8% | US$4.1b | US$56.36 | PS6.3x | E65.2% | n/a | Pharmaceuticals & Biotech | ||
CFLT | US$28.41 | -5.6% | 17.0% | US$8.9b | US$33.97 | PS11.4x | E12.0% | n/a | Software | ||
OCDO | UK£3.64 | -3.0% | -30.3% | UK£3.0b | UK£7.83 | PS1.1x | E10.4% | n/a | Consumer Retailing | ||
PING | US$28.50 | 0.4% | 4.5% | US$2.5b | US$28.44 | PS8x | E5.5% | n/a | Software |